Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis

Telimaa S, S Telimaa, Sakari Telimaa, A Kauppila, Antti Kauppila, Kauppila A, L Rönnberg, Rönnberg L, Lars Rönnberg, Suikkari AM, A M Suikkari, Anne‐Maria Suikkari, Seppälä M, Markku Seppällä, M Seppälä
American journal of obstetrics and gynecology · 1989 · vol. 161(4) , pp. 866–871 · doi:10.1016/0002-9378(89)90738-2 · PMID:2801831 · W2079510420
article OA: closed CC0 ⤵ 32 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This paper investigated the levels of endometrial secretory protein PP14 in patients with advanced endometriosis and found them to be elevated.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The circulating concentration of endometrial protein PP14 varied during the menstrual cycle in patients with endometriosis. The highest levels were found on days 1 to 4 of the cycle (176 +/- 123 micrograms/L; mean +/- SD), and the lowest on days 5 to 20 (44.1 +/- 29.7 micrograms/L). Rising levels were observed on days 21 to 30 (58.3 +/- 62.6 micrograms/L). On days 5 to 20 (i.e., during period of the lowest levels) patients with advanced endometriosis had higher PP14 levels (63.9 +/- 39.0 micrograms/L) than those with mild endometriosis (29.3 +/- 18.2 micrograms/L; p less than 0.01). Patients with mild endometriosis had slightly higher serum PP14 levels than apparently healthy control subjects (p less than 0.05), but overlapping of values between the two groups is remarkable. Conservative surgical elimination of endometriosis significantly decreased the serum PP14 levels. Treatment with danazol (600 mg/day), or with medroxyprogesterone acetate (100 mg/day) after laparoscopy also resulted in significant decreases in the serum PP14 concentration. After 6 months of treatment, conservative surgery in combination with danazol or with medroxyprogesterone acetate, yielded more pronounced declines in serum PP14 level than conservative surgery plus placebo. No significant difference was observed between the effects of danazol and medroxyprogesterone acetate. We conclude that endometriosis tissue contributes to the circulating PP14 level, and the decline in PP14 level during danazol and medroxyprogesterone acetate treatments reflects regression of intrauterine and ectopic endometrial tissues.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Glycoproteins Pregnancy Proteins Adult Combined Modality Therapy Danazol Danazol Endometriosis Endometriosis Female Glycodelin Humans Medroxyprogesterone Medroxyprogesterone Menstrual Cycle Menstrual Cycle Pregnancy Proteins

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Cited by (31)

Source provenance

europepmc
last seen: 2026-08-14T06:11:53.302379+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:10.744835+00:00
unpaywall
last seen: 2026-08-14T06:25:32.811723+00:00
License: CC0 · commercial use OK